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We demonstrate byimmunopreoipitation that u-PAR is associated with a 38 kDa protein that is phosphorylated on tyrosine after u-PA treatment 
of cells. As tyrosine phosphorylation is the hallmark of many signal transduction pathways that promote growth and differentiation, these data 
suggest hat u-PA, besides its role as a regulatory protease, might act as a para- or autocrine hormone. 
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1. INTRODUCTION bovine endothelial cells and the chemotaxis of human 
neutrophils [8]. 
Generation of the protease plasmin from its zymogen 
plasminogen, catalyzed by plasminogen activators 
(PAS), is frequently associated with biological processes 
requiring tissue remodelling and cell migration, such as 
involution of the mammary gland, trophoblast inva- 
sion, spermatogenesis, wound healing and malignant 
growth [l]. The biosynthesis of the components of the 
plasminogen activating system is under complex 
hormonal control [2]. Recently a high-affinity receptor 
for urokinase-type plasminogen activator (u-PAR) was 
isolated and characterized [3,4]. u-PAR, a 313-residue 
single polypeptide with five potential N-linked glycosyl- 
ation sites and a high content of cysteines, is fixed to the 
plasma membrane via a COOH-terminal glycosyl 
phosphoinositol (GPI) anchor [5,6] and believed to pro- 
vide a lever for the regulation of extracellular proteoly- 
sis by restricting the activity of u-PA temporally and 
topologically. As other GPI-linked proteins, such as 
Ly-6, have been implicated in signal transduction [7] we 
have explored a similar role of u-PAR. Previous work 
has shown that u-PA stimulates the differentiation of 
HL60 cells and mouse cells as well as the migration of 
In the present study we demonstrate that u-PA in- 
duces a dose-dependent phosphorylation of a 38 kDa 
protein (~38) on tyrosine in U-937 (histiocytic lym- 
phoma) cells. 
2. EXPERIMENTAL 
2.1. Materials 
Chemicals were of the best commercial grade available and pur- 
chased from Sigma (St. Louis, MO), Pharmacia (Uppsala, Sweden) or 
Serva (Heidelberg, Germany). [‘*P]ATP, [3SS]methionine a d lz51 were 
obtained from Amersham International. Purified rabbit anti- 
phosphotyrosine polyclonal antibodies were from Dianova (Ham- 
burg, Germany), PI-specific PLC from Sigma, the protein tyrosine 
kinase inhibitor herbimycin A (Streptomyces spp.) was obtained from 
Calbiochem Biochemical (San Diego, USA), u-PA from Serono 
(Freiburg, Germany). 
2.2. Cell culture 
U-937 cells were obtained from the American Type Culture Collec- 
tion and grown at 37°C in RPM1 1640 medium containing 5% fetal 
bovine serum. For [“Slmethionine labeling of the cellular proteins 
2 x 10’ U-937 cells/ml were seeded into 9 cm Petri dishes in 8 ml RPM1 
1640 containing 10% of the standard methionine concentration, 5% 
fetal bovine serum and 3&i/ml [‘?j]methionine. Cells were incubated 
for 3 days and harvested by centrifugation (1,000 x g, 10 min, 4°C). 
Correspondence address: I. Dumler, Institute of Cellular and Molecu- 
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2.3. PurQication of u-PAR 
u-PAR was purified in two steps, consisting of temperature-induced 
phase separation and affinity chromatography with immobilized u- 
PA, as previously described [9]. 
Abbreviations: u-PA, urokinase-type plasminogen activator; u-PAR, 
u-PA receptor; PMA, phorbol 12-myristate 13-acetate; DFP, diiso- 
propyl fluorophosphate; DSS, disuccinimidyl suberate; PBS, phos- 
phate buffered saline; SDS, sodium dodecyl sulphate; PAGE, poly- 
acrylamide gel electrophoresis; DTT, dithiothreitol; BSA, bovine 
serum albumin. 
2.4. Radio-iodination and cross-linking assay 
DFP-inhibited u-PA was iodinated by the Iodo-gen procedure [lo]. 
The iodinated protein was separated from free iodine by gel filtration 
on a Sephadex G-25 column. The specificity activity of labeled u-PA 
was approximately 15 ,Ki/mg protein. 
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For cross-linking experiments crude cell lysates or purified receptor 
preparations were incubated with DFP-inactivated radiolabeled u-PA 
for 1 h at 4°C followed by incubation with 1 mM DSS for 15 min at 
room temperature, and with 10 mM CH,COONH, for a further 10 
min. Samples were analyzed by SDS-PAGE, followed by radioauto- 
graphy. 
2.5. Preparation of rabbit anti-u-PAR serum 
The protein band corresponding to purified u-PAR was sliced out 
of the gel after SDS-PAGE and homogenized in 100 ~1 of elution 
buffer (50 mM NH,HCO,, 0.1% SDS). The first injections (subcutane- 
ous) consisted of 10 pg of protein per animal and were followed by 
two further treatments (5 lug of protein per animal). The serum was 
prepared 5 days after the last booster injection. 
2.6. Electrophoresis, Western blotting and radioautography 
SDS-PAGE was carried out in slab gels (7.5 or 10%) as described 
[l 11. Samples were reduced immediately before electrophoresis n the 
presence of 20 mM D’IT for 5 min at 95°C or analysed under non- 
reducing conditions. 
Gels were electroblotted onto nitrocellulose sheets which were sub- 
sequently blocked with 1% BSA or 30% fetal calf serum. Alkaline 
phosphatase-conjugated goat anti-rabbit Ig was used as a second 
antibody and the sheets developed with Nitro blue tetrazolium/5- 
bromo4-chloro-3-indolyl phosphate. Radioautography of ?, ‘?S, 
and “P-labeled proteins was performed with dried polyacrylamide gels 
using Konica X-ray film. In some experiments gels containing samples 
from immune protein tyrosine kinase assays were soaked in 1 N KOH 
at 55°C for 2 h to hydrolyze phosphate on serine and threonine [12]. 
2.7. Immunoprecipitation and immune complex kinase assay 
Protein samples were incubated for 2 h at 4°C with 25 ~1 of protein 
A Sepharose (Sigma), that had been incubated previously with 10 ~1 
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of anti-u-PAR antibody, overnight. The resin was subsequently sedi- 
mented by centrifugation and washed twice with 300 ~1 of 25 mM 
HEPES, pH 7.4,150 mM NaCl, 1 mM sodium orthovanadate or 0.5% 
Nonidet P-40, and twice with buffer without Nonidet P-40. To per- 
form the immune complex kinase assay, the immunoprecipitate was 
washed further with 25 mM HEPES, pH 7.4, 10 mM MnCl, contain- 
ing a protease inhibitor mixture (1 mM phenylmethylsulfonyl fluoride, 
and 10v6 M each of aprotinin, pepstatin and cystatin). Following the 
addition of 5 mM p-nitrophenylphosphate and 30 nM [“P]ATP the 
immunoprecipitates were incubated for 10 min at room temperature 
and subsequently washed for a final time in 20 mM HEPES, pH 7.4. 
After addition of SDS-sample buffer (with DTT) the immunoprecipi- 
tates were boiled and electrophoresed on 10% SDS-PAGE. After the 
separation the gels were dried and subjected to radioautography. 
2.8. Protein determination 
Protein was quantified with a bicinchoninic acid (BCA) reagent 
from Pierce, using BSA as a standard. 
3. RESULTS AND DISCUSSION 
u-PAR purified from U-937 cells was electrophoreti- 
tally homogeneous (Fig. la). Cross-linking with iodi- 
nated u-PA revealed a single band corresponding to the 
complex of u-PA/u-PAR exhibiting a M, of 110 kDa 
(Fig. lb). Antisera raised in rabbits against pure u-PAR 
recognized the receptor in purified fractions, as well as 
in crude cell extracts (Fig. lc). Immunoprecipitation of 
protein extracts of metabolically ([3’S]methionine) la- 
beled native U-937 cells was performed and two main 
C 
55k 
anti-u-PAR preimmune 
antibodies serum 
Fig. 1. (a) Purification of u-PAR. The lysis of U-937 cells, temperature-induced phase-separation and affinity chromatography were done as 
described in section 2. Lanes: 1,2, oily phase fractions; 3,4, water-soluble phase fractions; 5-8, fractions after affinity chromatography. (b) 
Cross-linking of radio-iodinated u-PA with u-PAR. DFP-treatment of u-PA and chemical cross-linking with DSS were performed as described. 
Lane 1, cross-linked control with [‘251]~-PA; lane 2, cross-linked u-PAR purified by affinity chromatography. (c) Characterization of antibodies 
raised to u-PAR. 20 pg of cell lysates or 0.5 pug of purified u-PAR were electrophorescd on 10% SDS-PAGE, transferred to nitrocellulose, and 
probed with immune or preimmune serum (as indicated). Immunoreactive proteins were identified by incubation with alkaline phosphatase- 
conjugated second antibody. 
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protein bands were revealed on autoradio~ams (Fig. 
2a). One of them, according to &f, and immunoreactiv- 
ity, corresponded to u-PAR, whereas the identity of the 
other band (M, 38 kDa: ~38) remains unknown. A third 
minor band co-migrated with the front line and con- 
tained material which has not been characterized and is 
therefore not further considered in the context of this 
work. 
With previous data on the association of several GPI- 
anchored proteins with protein tyrosine kinase activity 
in mind [7], we used commercial polyclonal anti-(P)Tyr 
antibody to test whether it reacted with ~38. The results 
indicate the presence of phosphotyrosine (Fig. 2b). 
In vitro phosphorylation of proteins precipitated with 
anti-u-PAR antibody resulted in labeling of ~38. The 
band was resistant to alkaline hydrolysis, indicating 
phosphorylation on tyrosine (data not shown). The 
phospho~lation was dependent on the dose of u-PA in 
the cell culture medium (Fig. 3a). 
In another experiment we removed CPI-linked pro- 
teins from the surface of the cells by treatment with 
PI-specific PLC before immunoprecipitation. This 
treatment significantly decreased the phosphorylation 
of p38 (Fig. 3b). Hence, intact GPI-linked u-PAR is 
necessary for the association with protein and phospho- 
rylation. Preincubation of U-937 cells with the protein 
kinase inhibitor, herbimycin A, also abolished the u- 
PA-induced phosphorylation of ~38 (Fig. 3b). 
Taken together our results demonstrate that u-PAR 
is (i) associated with ~38, a protein that is co-precipi- 
tated by polyclonal anti-u-PAR antisera, and (ii) 
phosphorylated on tyrosine upon the addition of ATP. 
Some aspects of these findings deserve brief comment. 
u-PAR so far has been purified exclusively from cells 
stimulated with PMA. This treatment increases the 
number of receptors but conco~t~tly leads to a lower 
affinity for u-PA [ 13,141. Such an effect could be ex- 
a 
-55k 
-38k 
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plained either by the bios~~esis of a modified receptor 
or the dissociation of a cofactor from the receptor upon 
addition of PMA. As we wanted to obtain antisera 
against the constitutive high-affinity receptor we chose 
to purify it from native U-937 cells and utilize it for the 
immunization. it seems urprising that ~38 did not co- 
purify with u-PAR on the u-PA-Sepharose. This may be 
due to the extraction procedure or to the conditions 
employed during charging and washing of the column. 
Alternatively ~38 could be synthesized at a higher rate 
than u-PAR, leading to a higher percentage of 35S incor- 
poration, or contain a si~~cantly higher proportion of 
met~onine so that the roughly equal intensity of bands 
in Fig. 2a could represent similar amounts of radio- 
activity but not equimolar amounts of protein. If 
[Y~~P]ATP is added to the immunoprecipitates, ~38 is 
phosphorylated on tyrosine. This is demonstrated both 
by the use of phosphot~os~e”s~ific monoclonal anti- 
body (Fig. 2b) as well as basic hydrolysis of the modi- 
fied tyrosine residues (data not shown). The tyrosine 
phosphorylation is dose dependent (Fig. 3a), abrogated 
by (i) herbimycin A, an inhibitor of tyrosine kinase, and 
(ii) treatment of the cells with phospholipase C, which 
cleaves GPI-linked proteins off the cell surface, estab- 
lishing an unequivocal ink between the occupation of 
the receptor and tyrosine kinase activity. The phospho- 
rylation may be autocatalytic or due to an enzyme that 
remains to be identified. Another open question con- 
b 
Fig. 2. (a) bnmunoprecipitation of in x&o-labeled U-937 cells. Cells were biosynthetically labeled with [35S]methionine and ~rn~opr~p~~tion 
using anti-u-PAR was done as described. All samples were resolved by SDS-PAGE, after which the gels were dried and analysed by autoradiogra- 
phy. Different amounts of cell Iysates were used for immunoprecipitation: lanes 1,2,25$g protein; lanes 3,4,5Opg protein; lanes 5,6,1OO,ug protein. 
(b) Western blotting of co-immunoptecipitated proteins with anti-(P)Tyr antibodies. The lysate of 2 x 106 U-937 cells preincubated with 100 nM 
u-PA for 1 h at 37°C was used for immunoprecipitation with anti-u-PAR antibodies. Commercial polyclonal anti-(P)Tyr antibody and alkaline 
phosphatase-conjugated second antibody were used for Western blot analysis. 
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Fig. 3. (a) Dose-dependency of p38 protein phosphorylation on the concentration of u-PA. U-937 cells (2 x 106) were incubated at 37°C for 1 h 
in the presence of different concentrations of u-PA. After that the immunoprecipitation and phosphorylation were done as described. (b) Effect 
of treatment of U-937 cells with PI-PLC (2 ,ul/2 x 10’ cells) and herbimycin A (1 ,uM/2 x lo5 cells) on co-precipitation and phosphorylation of ~38. 
The cells were treated with the indicated amount of drugs for 1 h at 37°C. Immunoprecipitation and in vitro kinase assay were performed as 
described. 
terns the biological function of p38 tyrosine phospho- 
rylation. As the u-PA receptor has been implicated in 
signal transduction [5,15], tyrosine phosphorylation 
may be an early event in the activation of a u-PAR- 
mediated signal transduction pathway. Alternatively it 
may play a role in the mechanism of receptor internali- 
zation. Current experiments are directed towards the 
elucidation of this question. 
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